Sanathan Biomedics Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 31-07-2024
- Paid Up Capital ₹ 2.00 Cr
as on 31-07-2024
- Company Age 24 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.43 Cr
as on 31-07-2024
- Revenue -12.10%
(FY 2023)
- Profit 28.01%
(FY 2023)
- Ebitda 65.03%
(FY 2023)
- Net Worth -2.94%
(FY 2023)
- Total Assets 2.62%
(FY 2023)
About Sanathan Biomedics
The Corporate was formerly known as Sanathana Ayurvedic Remedies (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹1.43 Cr.
Alla Babu and Ratna Gandla serve as directors at the Company.
- CIN/LLPIN
U51496TG2000PTC034381
- Company No.
034381
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sanathan Biomedics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alla Babu  | Director | 15-Dec-2022 | Current |
| Ratna Gandla | Director | 09-Mar-2023 | Current |
Financial Performance of Sanathan Biomedics.
Sanathan Biomedics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.1% decrease. The company also saw a substantial improvement in profitability, with a 28.01% increase in profit. The company's net worth dipped by a decrease of 2.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanathan Biomedics?
In 2023, Sanathan Biomedics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 11 Nov 2021 | ₹1.33 M | Open |
Canara Bank Creation Date: 12 Jun 2020 | ₹1.00 M | Open |
Canara Bank Creation Date: 05 Jun 2020 | ₹2.00 M | Open |
How Many Employees Work at Sanathan Biomedics?
Sanathan Biomedics has a workforce of 27 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanathan Biomedics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanathan Biomedics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
